AI Summary
The US government, under President Joe Biden's administration, has negotiated to cap the prices of ten expensive and commonly used prescription drugs starting in 2026. This deal marks the first time Medicare is negotiating drug prices on behalf of its beneficiaries, including older individuals and those with disabilities.
The prices of ten of the most expensive and widely used prescription drugs in the USA are to be capped from 2026, under a deal reached by drug manufacturers and US President Joe Biden’s administration, which was negotiating for the first time on behalf of Medicare, the public health insurance programme for people aged 65 years or older and for younger people with disabilities, including those with end stage renal disease and amyotrophic lateral sclerosis.